Published in Br J Cancer on July 01, 1989
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26
Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer (1991) 2.18
Predicting mortality from cervical cancer after negative smear test results. BMJ (1992) 2.01
PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol (2000) 1.73
The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol (2004) 1.55
Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48
Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.42
Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. Am J Pathol (1991) 1.14
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer (2004) 1.08
Detection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization. J Clin Microbiol (1995) 1.02
Non-progression of cervical intraepithelial neoplasia estimated from population-screening data. Br J Cancer (1997) 1.00
Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer (1995) 0.97
Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer (2000) 0.91
Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. Br J Cancer (1990) 0.90
Cervical cancer screening. Br J Cancer (1990) 0.89
Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer (1996) 0.89
Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer (2000) 0.83
Rate of opportunistic pap smear screening and patterns of epithelial cell abnormalities in pap smears in ajman, United arab emirates. Sultan Qaboos Univ Med J (2012) 0.81
HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway. Cancer Med (2013) 0.80
Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study. BMJ (2016) 0.78
Extended duration of the detectable stage by adding HPV test in cervical cancer screening. Br J Cancer (2003) 0.77
Molecular screening of compounds to the predicted Protein-Protein Interaction site of Rb1-E7 with p53- E6 in HPV. Bioinformation (2012) 0.77
Does CIN2 Have the Same Aggressive Potential As CIN3? A Secondary Analysis of High-Grade Cytology Recurrence in Women Treated with Cold-Coagulation Cervical Treatment. Geburtshilfe Frauenheilkd (2017) 0.75
Withdrawing low risk women from cervical screening programmes. Conclusions cannot yet be drawn. BMJ (1999) 0.75
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Significance of in situ carcinoma of the uterine cervix. Br Med J (1962) 6.39
Cervical cancer detection in British Columbia. A progress report. J Obstet Gynaecol Br Commonw (1968) 5.43
Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol (1984) 5.36
The relationship between carcinoma in situ and invasive cervical carcinoma; a consideration of the contributions to the problem to be made from general population data. Cancer (1953) 5.26
Failures of the cervical cytology screening programme. Br Med J (Clin Res Ed) (1984) 3.25
Screening for cervical intraepithelial neoplasia in Dundee and Angus 1962-81 and its relation with invasive cervical cancer. Lancet (1985) 3.18
Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer (1984) 3.05
Changing patterns of cervical cancer rates. Br Med J (Clin Res Ed) (1983) 2.73
Evaluation of screening for cervical cancer in Sweden: trends in incidence and mortality 1958-1980. Int J Epidemiol (1985) 2.64
Observations on a model of the biology of carcinoma of the cervix: a poor fit between observation and theory. Am J Obstet Gynecol (1975) 2.07
Evaluation of screening programmes for gynaecological cancer. Br J Cancer (1985) 2.06
An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. J Epidemiol Community Health (1986) 2.02
Estimation of the screening error rate from the observed detection rates in repeated cercival cytology. Am J Obstet Gynecol (1974) 1.49
Perspectives on the epidemiology of cervical cancer with special reference to the herpesvirus hypothesis. Cancer Res (1974) 1.47
Spontaneous course of cervical precancerous conditions. Am J Obstet Gynecol (1956) 1.46
Morphogenesis of cervical cancer. Findings from San Diego County Cytology Registry. Cancer (1967) 1.35
A statistical model of the natural history of cervical neoplastic disease: the duration of carcinoma in situ. Gynecol Oncol (1978) 1.24
Invasive carcinoma of the cervix in Queensland. Change in incidence and mortality, 1959-1980. Med J Aust (1983) 1.24
An analysis of the prevalence and incidence of gynecologic cancer cytologically detected in a population of 175,767 women. Acta Cytol (1970) 1.21
A computer simulation model for the practical planning of cervical cancer screening programmes. Br J Cancer (1985) 1.13
Costs of detecting and treating cancer of the uterine cervix in North-East Scotland in 1971. Lancet (1975) 1.05
Evidence for the existence of two forms of cervical carcinoma. J Obstet Gynaecol Br Commonw (1966) 0.96
Uterine cancer in Connecticut: late deaths among 5-year survivors. J Natl Cancer Inst (1961) 0.94
Incidence and prevalence of preclinical carcinoma of cervix in a British population. Br J Obstet Gynaecol (1982) 0.94
Epidemiological evidence for two components of cervical cancer. Br J Obstet Gynaecol (1981) 0.87
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Stressful life events and Graves' disease. Lancet (1991) 3.63
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
[Meta-analysis is a good help for literature review. It makes the analysis of earlier studies more efficient and more objective]. Lakartidningen (1999) 2.02
Pesticides and cancer. Cancer Causes Control (1997) 2.00
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst (1993) 1.87
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet (1986) 1.79
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Country profile: Sweden. Lancet (1996) 1.76
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst (1996) 1.71
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer (1997) 1.69
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer (2000) 1.67
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology (1994) 1.64
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
Twin membership and breast cancer risk. Am J Epidemiol (1992) 1.62
Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol (1989) 1.62
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control (2000) 1.61
Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery (1987) 1.56
Maternal and perinatal risk factors for childhood leukemia. Cancer Res (1991) 1.55
Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer (1999) 1.55
Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst (1995) 1.53
International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer (1997) 1.50
Gender of offspring and maternal breast cancer risk. Int J Cancer (1999) 1.50
Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst (1994) 1.49
Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer (2001) 1.48
Extracolonic malignancies in inflammatory bowel disease. Cancer (1991) 1.47
Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer (1993) 1.46
The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia (1999) 1.45
Relationship between age and survival in cancer of the colon and rectum with special reference to patients less than 40 years of age. Br J Surg (1990) 1.45
Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst (1996) 1.44
Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet (1987) 1.42
Does age at the last birth affect breast cancer risk? Eur J Cancer (1996) 1.42
Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer (1997) 1.42
Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control (1999) 1.42
Re: Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol (1996) 1.41
Serum concentrations of organochlorines in men: a search for markers of exposure. Sci Total Environ (2000) 1.40
Melanoma in pregnancy. Lancet (1991) 1.39
Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat (1996) 1.39
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ (1989) 1.39
A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res (2000) 1.38
Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med (2001) 1.38
Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol (1989) 1.38
Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med (1988) 1.36
Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35
Cholecystectomy and colorectal cancer. Gastroenterology (1993) 1.35
Reproductive history and risk of breast cancer: a case-control study in an unselected Swedish population. Cancer (1978) 1.33
IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer (1999) 1.32
The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol (1992) 1.32
Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst (1995) 1.28
Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Lancet (1989) 1.26
Response bias in a case-control study: analysis utilizing comparative data concerning legal abortions from two independent Swedish studies. Am J Epidemiol (1991) 1.26
The risk of gastrointestinal and other primary malignant diseases following gastric cancer. Acta Oncol (1991) 1.26
Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden) Cancer Causes Control (1998) 1.25
Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25